AstraZeneca

Israeli-founded AI biotech Immunai expands AstraZeneca cancer collaboration

The expanded agreement extends and broadens the companies’ multi-year collaboration in oncology through 2027, according to the statement.

A vial and sryinge are seen in front of a displayed AstraZeneca logo in this illustration taken January 11, 2021
Cancer (Illustrative)

Immunai, AstraZeneca collaborate to optimize cancer clinical trials

Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021.

US to move COVID-19 vaccines, treatments to private markets in 2023

AION Labs CEO Mati Gil.

AION, aMoon up for top scientific innovation award


AstraZeneca to miss 2nd-quarter EU vaccine supply by half - EU Official

AstraZeneca's contract with the EU, which was leaked last week, showed the company had committed to delivering 180 million doses to the 27-nation bloc in the second quarter.

The logo of AstraZeneca is seen on medication packages in a pharmacy in London

WHO lists AstraZeneca/Oxford COVID-19 vaccine for emergency use

A WHO statement said it had approved the vaccine as produced by AstraZeneca-SKBio (Republic of Korea) and the Serum Institute of India.

A vial and sryinge are seen in front of a displayed AstraZeneca logo in this illustration taken January 11, 2021

Coronavirus: Oxford U. to test COVID vaccine response on children

The new mid-stage trial will determine whether the vaccine is effective on people between the ages of 6 and 17, according to an emailed statement from the university.

A vial and sryinge are seen in front of a displayed AstraZeneca logo in this illustration taken January 11, 2021

UK: Astrazeneca vaccine prevents COVID-19 death, South Africa halts shots

South Africa will put on hold use of AstraZeneca's COVID-19 shot in its vaccination program.

A vial of the Oxford-AstraZeneca COVID-19 vaccine is seen at Basingstoke Fire Station, in Basingstoke, Britain February 4, 2021

COVID-19: AstraZeneca vaccine less effective against SA variant - study

Among coronavirus variants currently most concerning for scientists and public health experts are the so-called British, South African and Brazilian variants

A vial and sryinge are seen in front of a displayed AstraZeneca logo in this illustration taken January 11, 2021

AstraZeneca COVID-19 vaccine works against UK variant, Oxford says

That lockdown came as Britain started rolling out the AstraZeneca vaccine. Over 10 million people have received a first dose of either AstraZeneca or Pfizer's shot.

A vial of the Oxford-AstraZeneca COVID-19 vaccine is seen at Basingstoke Fire Station, in Basingstoke, Britain February 4, 2021

Britain trial to test combining Pfizer and AstraZeneca vaccines in 2-shot

The trial will examine the immune responses of an initial dose of Pfizer vaccine followed by a booster of AstraZeneca's, as well as vice versa, with intervals of 4 and 12 weeks.

A health worker draws a dose of the AstraZeneca's coronavirus disease (COVID-19) vaccine, at the vaccination center in the Newcastle Eagles Community Arena, in Newcastle upon Tyne, Britain, January 30, 2021.

Oxford kept COVID-19 vaccine trial volunteers in dark about dosing error

The dosing mishap was presented to the trial participants in a letter dated June 8 as an opportunity for University of Oxford researchers to learn how well the vaccine works at different doses.

A test tube labelled vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020.

AstraZeneca, EU end standoff, 9 mil. COVID-19 vaccines will be delivered

The Anglo-Swedish company unexpectedly announced earlier this month that it would cut supplies to the EU of its vaccine candidate in the first quarter, sparking a row over supplies.

French President Emmanuel Macron visits AstraZeneca factory in Dunkirk

Britain gives first dose of Oxford/AstraZeneca vaccine to dialysis patient

He said he was looking forward to celebrating his 48th wedding anniversary with wife Shirley in February.

A test tube labelled vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020.